New Report Tracks Trends in AIDS Drug Assistance Programs
The National Alliance of State and Territorial AIDS Directors, the Kaiser Family Foundation and the AIDS Treatment Data Network today released a number of new reports and fact sheets on states' AIDS Drug Assistance Programs, which use federal funds to provide prescription drugs for uninsured and low-income individuals with HIV/AIDS. A synopsis of each of these materials is included below:
- National ADAP Monitoring Report 2002: The annual monitoring report tracks ADAP spending and access over the past year and examines long-term trends in the program. The 2002 report found that the number of clients served by ADAPs increased by 10% between June 2000 and June 2001, a slower growth rate than seen in previous years. ADAP enrollment grew 144% between 1996 -- the first year of the ADAP Monitoring Project -- and 2001. Meanwhile, ADAP drug expenditures grew to nearly $64 million in June 2001 -- a 16% increase from June 2000 -- and total ADAP drug expenditures grew 320% between 1996 and 2001. The national ADAP budget reached $810.2 million in June 2001, rising 12% from the year before and 329% since fiscal year 1996. Ten states or territories reported having one or more ADAP restrictions, including capped enrollment, limited antiretroviral access or expenditure caps (National ADAP Monitoring Report 2002, April 2002).
- HIV/AIDS Policy Fact Sheet: The HIV/AIDS Policy fact sheet on ADAPs outlines the demographic profile of ADAP clients, ADAP budget trends and restrictions that individual states have placed on their ADAPs.
- Issue Brief: "AIDS Drug Assistance Programs -- Getting the Best Price?" outlines different cost containment strategies that states can adopt for their ADAPs ("AIDS Drug Assistance Programs -- Getting the Best Price?" April 2002).